JUL 12, 2022 8:30 AM PDT

Nitric Oxide Reduces Hospital Stay of Pregnant Women with COVID-19

WRITTEN BY: Annie Lennon

High-dose nitric oxide can reduce the length of hospital and ICU stay, as well as the need for supplemental oxygen, among women with COVID-19 pneumonia. The treatment is also not associated with adverse effects on newborns. The corresponding study was published in Obstetrics and Gynecology

"Compared to non-pregnant female patients with COVID-19, pregnant women are three times more likely to need intensive care unit admission, mechanical ventilation, or advanced life support, and four times more likely to die," said Carlo Valsecchi, MD, lead author in the Department of Anesthesia, Critical Care and Pain Medicine, MGH. "They also face a greater risk of obstetric complications such as preeclampsia, preterm delivery, and stillbirth."

Nitric oxide was originally approved by the US Food and Drug Administration in 1999 for inhalation treatment of intubated and mechanically ventilated newborns with hypoxic respiratory failure. Recent reports demonstrated that high dose nitric oxide was linked to favorable outcomes among pregnant patients with COVID-19. As such, the researchers behind the present study decided to determine the safety and efficacy of high-dose nitric oxide for COVID-19 pneumonia in pregnancy. 

To do so, they observed 71 pregnant patients with severe COVID-19 pneumonia. Twenty of the patients received 30 minutes of high dose nitric oxide twice per day in addition to standard of care, whereas the remaining 51 patients received standard of care alone. The researchers then noted how many days patients had free of oxygen supplementation 28 days postadmission.

In the end, they found that receiving high-dose nitric oxide was linked to 63.2% more days free from oxygen supplementation, a 59.7% shorter ICU length of stay, and a 63.6% shorter hospital length of stay than standard care alone. 

"Being able to wean patients from respiratory support quicker could have other profound implications, including reducing stress on women and their families, lowering the risk of hospital-acquired infections, and relieving the burden on the health care system," said senior author Lorenzo Berra, MD, with the Department of Anesthesia, Critical Care and Pain Medicine, MGH.

"Above all, our study supports the safety of high dose nitric oxide in the pregnant population, and we hope more physicians will consider incorporating it into carefully monitored treatment regimens," he added. 


Sources: Science Daily, Obstetrics and Gynecology

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
AUG 02, 2022
Cell & Molecular Biology
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
AUG 02, 2022
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
Introduction Centrifugation and filtration have been widely accepted as techniques required for clarifying complex cell ...
JUL 14, 2022
Plants & Animals
Using Worms to Study Precision Medicine
JUL 14, 2022
Using Worms to Study Precision Medicine
Personalized medicine refers to making decisions about treatment that are optimized to a specific individual, often as a ...
AUG 12, 2022
Cannabis Sciences
Study Shows Water Soluble CBD Has Better Absorption than Oil-Based CBD Products
AUG 12, 2022
Study Shows Water Soluble CBD Has Better Absorption than Oil-Based CBD Products
Colorado State University researchers examined the pharmacokinetics of cannabidiol (CBD) and its impact on liver functio ...
AUG 11, 2022
Cannabis Sciences
High Doses of CBD Safe for Driving
AUG 11, 2022
High Doses of CBD Safe for Driving
The University of Sydney research team studied the effects of cannabidiol (CBD) on driving, and they found that the high ...
AUG 07, 2022
Drug Discovery & Development
Monoclonal Antibody Treatment Shows Promise in Preventing Malaria
AUG 07, 2022
Monoclonal Antibody Treatment Shows Promise in Preventing Malaria
A singular injection of a monoclonal antibody treatment candidate has been shown as safe and highly protective in US adu ...
AUG 17, 2022
Neuroscience
The Research Value of Patient Medical Records and Samples
AUG 17, 2022
The Research Value of Patient Medical Records and Samples
A majority of patients want notification about the potential uses of their medical records or samples according to a stu ...
Loading Comments...